We chat with Anna Marie Wagner, the SVP of corporate development at Gingko Bioworks, a synthetic biology company that recently came public and is part of Invest Vegan's flagship strategy. We chat about how Gingko evolved its funding sources over time, the firm's decision to pursue a horizontal/service provider business model, and how she'll judge the success of her company and the broader synthetic biology industry going forward.
Free Money with Sloane and Ashby
Most sane people have given up hope that the finance industry can be a catalyst for positive change, but not Sloane Ortel and Ashby Monk. Since Free Money launched in 2019, they have helped listeners understand the true power (and immense potential) of long-term investing through accessible, authoritative, and deeply irreverent conversations with others pushing for progress. In the process, they’ve helped literally dozens of listeners understand root causes of the industry’s misalignment with the modern world and radicalized them into pushing for positive change.
Most sane people have given up hope that the finance industry can be a catalyst for positive change, but not Sloane Ortel and Ashby Monk. Since Free Money launched in 2019, they have helped listeners understand the true power (and immense potential) of long-term investing through accessible, authoritative, and deeply irreverent conversations with others pushing for progress. In the process, they’ve helped literally dozens of listeners understand root causes of the industry’s misalignment with the modern world and radicalized them into pushing for positive change.Listen on
Substack App
Spotify
RSS Feed
Recent Episodes
Share this post